Author:Sciensus

rare and orphan diseases

Blogs, Rare diseases

Early access programs – benefits, challenges and the Sciensus solution
Thought leadership - strategies for entering european market

Thought Leadership, Rare diseases

Strategies for entering the European orphan drugs market 
Sciensus_Fierce Biotech_white paper_final

Thought Leadership, Rare diseases

Realise your European orphan drug expansion
Thought Leadership Supply Chain - Rare

Thought Leadership, Rare diseases

Take the risk out of your orphan drug distribution in Europe
Navigating regulatory challenges in the EU

Thought Leadership, Rare diseases

EU orphan drug roll out: navigating regulatory challenges
Integrating clinical studies and Patient Support Programs- Sciensus

Thought Leadership, Rare diseases

Integrating clinical studies and Patient Support Programs(PSPs) for holistic rare disease care